Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

First Belgian Notified Body Appointment Brings EU MDR Total To 25

Executive Summary

Every new notified body designation under the Medical Device Regulation is being welcomed by medtech companies as the countdown continues for the grace period to end in May 2024.

You may also be interested in...



MHRA's Graeme Tunbridge Joins BSI Notified Body

Graeme Tunbridge is looking forward to a new career with notified body, BSI, after nearly two decades as a civil servant. But where does his departure leave the UK MHRA at a time of critical change?

EU Now Boasts 27 MDR Notified Bodies With Latest Italian Designation

Demand for notified body certification under the Medical Device Regulation is predicted to grow exponentially over the next two years. Two new organizations have been designated in 2022 already.

Two MDR-Designated European Notified Bodies Become One

Norwegian notified body DNV acquires German competitor in move intended to address the peak in Medical Device Regulation certification demands.

Topics

UsernamePublicRestriction

Register

MT144773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel